MRC1 and breast cancer: Immunofluorescence analysis (Figure 4A) revealed that LA@BC treatment significantly reduced the expression of iNOS (M1 marker, red) and increased the expression of CD206 (M2 marker, green), while DAPI (blue) stained nuclei consistently across all groups.